Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients.
Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients.
复制标题
DOI:
10.1371/journal.pone.0078686
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Rufer N
中科院分区:
文献类型:
--
作者:
Iancu EM;Gannon PO;Laurent J;Gupta B;Romero P;Michielin O;Romano E;Speiser DE;Rufer N
Persistent viruses are kept in check by specific lymphocytes. The clonal T cell receptor (TCR) repertoire against Epstein-Barr virus (EBV), once established following primary infection, exhibits a robust stability over time. However, the determinants contributing to this long-term persistence are still poorly characterized. Taking advantage of an in vivo clinical setting where lymphocyte homeostasis was transiently perturbed, we studied EBV antigen-specific CD8 T cells before and after non-myeloablative lympho-depleting chemotherapy of melanoma patients. Despite more advanced T cell differentiation, patients T cells showed clonal composition comparable to healthy individuals, sharing a preference for TRBV20 and TRBV29 gene segment usage and several co-dominant public TCR clonotypes. Moreover, our data revealed the presence of relatively few dominant EBV antigen-specific T cell clonotypes, which mostly persisted following transient lympho-depletion (TLD) and lymphocyte recovery, likely related to absence of EBV reactivation and de novo T cell priming in these patients. Interestingly, persisting clonotypes frequently co-expressed memory/homing-associated genes (CD27, IL7R, EOMES, CD62L/SELL and CCR5) supporting the notion that they are particularly important for long-lasting CD8 T cell responses. Nevertheless, the clonal composition of EBV-specific CD8 T cells was preserved over time with the presence of the same dominant clonotypes after non-myeloablative chemotherapy. The observed clonotype persistence demonstrates high robustness of CD8 T cell homeostasis and reconstitution.
登录
查看更多内容
DOI:
10.1038/nrc3322
发表时间:
2012-10
期刊:
Nature reviews. Cancer
影响因子:
--
作者:
Gattinoni L;Klebanoff CA;Restifo NP
通讯作者:
Restifo NP
影响因子:
30.5
作者:
Kaech, SM;Tan, JT;Ahmed, R
通讯作者:
Ahmed, R
影响因子:
4.1
作者:
Fonseca, Simone G.;Procopio, Francesco A.;Sekaly, Rafick-Pierre
通讯作者:
Sekaly, Rafick-Pierre
影响因子:
4.4
作者:
Iancu, Emanuela M.;Corthesy, Patricia;Rufer, Nathalie
通讯作者:
Rufer, Nathalie
影响因子:
45.3
作者:
Dudley, ME;Wunderlich, JR;Rosenberg, SA
通讯作者:
Rosenberg, SA